文献速递其他结缔组织病

高多基因风险评分与原发性舍格伦病SSA/SSB抗体阳性及早发相关

A high polygenic risk score is associated with SSA/SSB antibody positivity and early onset in primary Sjögren's disease.
PubMed 文献 · Rheumatology (Oxford) · 2025-01-01

在1065例原发性舍格伦病患者与7742例对照中构建含或不含HLA区域变异的多基因风险评分(PRS)。高PRS与SSA抗体阳性(OR 9.16)及SSA/SSB双抗体阳性(OR 13.67)相关,抗体阴性患者PRS与对照相似;高PRS四分位组诊断年龄更轻(48.9±14.9 vs 53.4±13.4岁)。

要点

  • 高PRS与SSA抗体阳性舍格伦病相关(OR 9.16,95%CI 7.75-10.85),SSA/SSB双阳性者关联更强(OR 13.67,95%CI 10.88-17.32)。
  • 不含HLA的PRS与SSA/SSB阳性舍格伦病的关联较弱(OR 2.09,95%CI 1.71-2.55)。
  • 高PRS四分位组诊断年龄更轻(48.9±14.9 vs 53.4±13.4岁),ANA、SSA及SSA/SSB抗体频率更高(P<1×10-5)。

核心结论

  • 高PRS与SSA/SSB抗体阳性及较早发病相关,二者很大程度上归因于HLA等位基因的权重。
  • 作者认为将PRS与其他生物标志物整合应用于临床表型,可能成为疾病风险分层和治疗决策的有用工具。

研究设计与样本

  • 研究纳入1065例原发性舍格伦病患者,采用Illumina OmniExpressExome芯片进行基因分型,对照基因型数据7742例。
  • 构建两种PRS:一种包含HLA基因变异(21个SNV),另一种不含HLA(18个SNV);将高PRS四分位(Q4)个体与低PRS(Q1-3)比较。

主要发现

  • 高PRS与SSA抗体阳性舍格伦病相关(OR 9.16,95%CI 7.75-10.85,P=3.7×10-146),在SSA/SSB双抗体阳性者中关联更强(OR 13.67,95%CI 10.88-17.32,P=4.6×10-108)。
  • 高PRS区分SSA/SSB抗体阳性舍格伦病的准确性很好(AUC 0.86)。
  • 不含HLA的PRS与SSA/SSB阳性舍格伦病的关联较弱(OR 2.09,95%CI 1.71-2.55,P=6.4×10-13)。
  • 抗体阴性舍格伦病患者的PRS与对照相似。
  • 高PRS四分位组诊断年龄显著更轻,为48.9±14.9岁,低PRS四分位组(Q1-3)为53.4±13.4岁,P=2.2×10-6;高PRS组ANA、SSA及SSA/SSB抗体频率更高,P<1×10-5。

临床怎么用

  • 作者认为将PRS与其他生物标志物整合应用于临床表型,可能成为疾病风险分层和治疗决策的有用工具。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To calculate a polygenic risk score (PRS) based on single nucleotide variants (SNVs) previously associated with primary Sjögren's disease (SjD) with genome-wide significance and determine the genetic risk for SjD stratified by antibodies, sex and age at diagnosis. METHODS: Patients with SjD (n = 1065) were genotyped using Illumina OmniExpressExome chip. Control genotype data were available (n = 7742). Two PRSs were constructed, one including HLA gene variants (n = 21 SNVs), and one without HLA (n = 18 SNVs). High PRS quartile (Q4) individuals were compared with low PRS (Q1-3). RESULTS: A high PRS was associated with SSA antibody-positive SjD (OR 9.16, 95% CI 7.75-10.85, P = 3.7 × 10-146), and strengthened in SjD positive for both SSA/SSB antibodies (OR 13.67, 95% CI 10.88-17.32, P = 4.6 × 10-108). High PRS classified SSA/SSB antibody-positive SjD with very good accuracy (AUC 0.86). PRS without HLA showed a weaker association with SSA/SSB positive SjD (OR 2.09, 95% CI 1.71-2.55, P = 6.4 × 10-13). Antibody negative SjD displayed a PRS similar to controls. Patients in the high PRS quartile were significantly younger at diagnosis, 48.9 ± 14.9 vs 53.4 ± 13.4 years in the low PRS quartiles (Q1-3), P = 2.2 × 10-6, and presented higher frequencies of ANA, SSA and SSA/SSB antibodies, P < 1 × 10-5. CONCLUSION: A high PRS is associated with SSA/SSB antibody positivity and early disease onset, both largely attributed to the weight of the HLA alleles. Integration of PRS with other biomarkers applied to clinical phenotypes could be a useful tool for disease risk stratification and treatment decisions.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Fugmann C, Reid S, Pucholt P, et al. A high polygenic risk score is associated with SSA/SSB antibody positivity and early onset in primary Sjögren's disease. Rheumatology (Oxford). 2025. PMID: 39693120. doi:10.1093/rheumatology/keae693

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。